➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Merck
Mallinckrodt
Express Scripts
Colorcon
Boehringer Ingelheim

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

Drug Price Trends for HM MIGRAINE


Email this page to a colleague

« Back to Dashboard

Drug Price Trends for HM MIGRAINE

Average Pharmacy Cost for HM MIGRAINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HM MIGRAINE 250-250-65 MG CPLT 62011-0243-01 0.05645 EACH 2021-06-23
HM MIGRAINE 250-250-65 MG CPLT 62011-0463-01 0.05645 EACH 2021-06-23
HM MIGRAINE 250-250-65 MG CPLT 62011-0243-01 0.04927 EACH 2021-05-19
HM MIGRAINE 250-250-65 MG CPLT 62011-0463-01 0.04927 EACH 2021-05-19
HM MIGRAINE RELIEF CAPLET 62011-0243-01 0.04882 EACH 2021-04-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Colorcon
Moodys
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.